Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BRITISH JOURNAL OF CANCER 2020-03, Vol.122 (7), p.1119-1119
Hauptverfasser:	Ribi, Karin, Luo, Weixiu, Colleoni, Marco, Karlsson, Per, Chirgwin, Jacquie, Aebi, Stefan, Jerusalem, Guy, Neven, Patrick, Di Lauro, Vincenzo, Gomez, Henry L., Ruhstaller, Thomas, Abdi, Ehtesham, Biganzoli, Laura, Müller, Bettina, Barbeaux, Annelore, Graas, Marie-Pascale, Rabaglio, Manuela, Francis, Prudence A., Foukakis, Theodoros, Pagani, Olivia, Graiff, Claudio, Vorobiof, Daniel, Maibach, Rudolf, Di Leo, Angelo, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Regan, Meredith M., Bernhard, Jürg
Format:	Artikel
Sprache:	eng
Schlagworte:	631/477/2811 692/4028/67/1347 Biomedical and Life Sciences Biomedicine Cancer Research Correction Drug Resistance Epidemiology Human health sciences Molecular Medicine Oncologie Oncology Sciences de la santé humaine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An amendment to this paper has been published and can be accessed via a link at the top of the paper.
ISSN:	0007-0920 1532-1827 1532-1827
DOI:	10.1038/s41416-019-0709-x